James Bearden 3rd
Overview
Explore the profile of James Bearden 3rd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kyi K, Consagra W, Culakova E, Berkhof L, Janelsins M, Conlin A, et al.
J Geriatr Oncol
. 2024 Apr;
15(5):101764.
PMID: 38616158
No abstract available.
2.
Jensen-Battaglia M, Lei L, Xu H, Loh K, Wells M, Tylock R, et al.
JCO Oncol Pract
. 2022 Aug;
18(10):e1630-e1640.
PMID: 35984998
Purpose: Falls are a modifiable source of morbidity for older adults with cancer, yet are underassessed in oncology practice. In this secondary analysis of a nationwide cluster-randomized controlled trial, we...
3.
Jensen-Battaglia M, Lei L, Xu H, Kehoe L, Patil A, Loh K, et al.
JAMA Netw Open
. 2022 Mar;
5(3):e223039.
PMID: 35302628
Importance: The functional status and physical performance of older adults with cancer are underassessed and undertreated despite the high prevalence of impaired functional status and physical performance in this population...
4.
Loh K, Mohamed M, Kadambi S, Culakova E, Xu H, Magnuson A, et al.
Oncologist
. 2021 Feb;
26(4):310-317.
PMID: 33523583
Background: Caregivers of adults with cancer often report a different understanding of the patient's prognosis than the oncologist. We examine the associations of caregiver-oncologist prognostic concordance with caregiver depressive symptoms,...
5.
Verduzco-Aguirre H, Babu D, Mohile S, Bautista J, Xu H, Culakova E, et al.
J Pain Symptom Manage
. 2020 Aug;
61(2):369-376.e1.
PMID: 32822750
Context: Older adults with advanced cancer face uncertainty related to their disease and treatment. Objectives: To evaluate the associations of uncertainty with psychological health and quality of life (QoL) in...
6.
Stinchcombe T, Janne P, Wang X, Bertino E, Weiss J, Bazhenova L, et al.
JAMA Oncol
. 2019 Aug;
5(10):1448-1455.
PMID: 31393548
Importance: Erlotinib is a standard first-line therapy for patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Median progression-free survival (PFS) with erlotinib is approximately 10 months....
7.
Loh K, Mohile S, Lund J, Epstein R, Lei L, Culakova E, et al.
Oncologist
. 2019 Apr;
24(6):e292-e302.
PMID: 31015317
Background: Ensuring older patients with advanced cancer and their oncologists have similar beliefs about curability is important. We investigated discordance in beliefs about curability in patient-oncologist and caregiver-oncologist dyads. Materials...